Skip to main content

CVE detail

CVE-2020-36289

Affected versions of Atlassian Jira Server and Data Center allow an unauthenticated user to enumerate users via an Information Disclosure vulnerability in the QueryComponentRendererValue!Default.jspa endpoint. The affected versions are before version 8.5.13, from version 8.6.0 before 8.13.5, and from version 8.14.0 before 8.15.1.

CVSS 5.3 · MediumBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • Hackers have started exploiting a critical remote code execution vulnerability that was patched recently in Atlassian Confluence Server and Data Center. Some of the attacks deploy cryptocurrency mining malware, but Atlassian products have also been targeted in the past by cyberespionage groups. “Bad Packets honeypots have detected mass scanning and exploit activity targeting the Atlassian […]

    newswww.csoonline.comSep 3, 2021, 11:35 AM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence